<! html public "-//W3C//DTD HTML 4.01 Transitional//EN">

<html>
<head>
<meta name="Sperowider-ArchiveRoot" content="../../../../../">
<meta name="Sperowider-DocRoot" content="../../../">
<meta name="Sperowider-OriginalURL" content="http://www.erowid.org/archive/rhodium/chemistry/shulgin.meo-34-dialkoxyamphetamines.html">
<title>A. T. Shulgin: Psychotomimetic Amphetamines - Methoxy 3,4-Dialkoxyamphetamines - [www.rhodium.ws]</title>
<link href="../styles.css" rel="stylesheet" type="text/css">

</head>

<body>
<div style="border:black solid 1px;">
<div style="border:white solid 1px; padding:.25em; color: white; font: 700 9pt arial,sans-serif; background-color: darkblue;">
This file is a part of the Rhodium site archive. This Aug 2004 static snapshot is hosted by Erowid<br>
as of May 2005 and is not being updated. <a href="../index.html" style="color:white;">&gt; &gt; Back to Rhodium Archive Index &gt; &gt; </a>
</div>
</div>

<div class="top">
<a href="../rhodium.html">[www.rhodium.ws]</a> [] <a href="index.html">[Chemistry Archive]</a>
<br><form method="get" action="http://www.erowid.org/cgi-bin/search/htsearch.php?method=and&restrict=www.erowid.org%2Farchive%2Frhodium%2F&words=barron"><input type="hidden" name="config" value=""><input type="hidden" name="restrict" value=""><input type="hidden" name="exclude" value=""><input type="text" size="29" name="words" value="">&nbsp;<input type="submit" value="Search"></form>
<div class="spacer">&nbsp;</div>
</div>

<div class="header">
<h2>Psychotomimetic Amphetamines:<br>Methoxy 3,4-Dialkoxyamphetamines<a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>1</sup></a></h2>
<h4>Alexander T. Shulgin<br>Experientia 20, 366-667 (1964)</h4>
<p>HTML by Rhodium</p>
</div>

<div class="stdtxt">

<p>Both 3,4,5-trimethoxyamphetamine (<strong>I</strong>, TMA)<a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>2</sup></a> and 3-methoxy-4,5-methylenedioxyamphetamine (<strong>II</strong>, MMDA)<a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>3</sup></a> have exhibited psychotropic potencies greater than that of mescaline. Both the lengthening of the aliphatic chain of <strong>I</strong><a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>4</sup></a> and the enlargement of the heterocyclic ring in <strong>II</strong><a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>3</sup></a> have resulted in a decreased human effectiveness. On the contrary, it has been found that the repositioning of the meta-methoxy group, in either of these compounds, to an available ortho-location, can result in an appreciable increase in potency. The syntheses and preliminary pharmacological evaluation of these positional isomers are described.</p>

<div class="pic right">
<img src="pictures/shulgin.meo-34-dialkoxy-a.gif" width="350" height="302"></div>

<p>Two methods of synthesis were employed. With the two bases possessing the 2,4,5-alkoxy orientation, the appropriately substituted propenylbenzene was oxidized with tetranitromethane to the corresponding &beta;-nitropropene. LiAlH<sub>4</sub> reduction of these nitrostyrenes to the amphetamines was performed as previously described<a href="shulgin.meo-34-dialkoxyamphetamines.html#refs"><sup>5</sup></a>. The propene required for <strong>III</strong>, asarone, was obtained by the fractional distillation of oil of Parsley. The necessary precursor of <strong>IV</strong>, 2-methoxy-4,5-methylenedioxy propenylbenzene was obtained by conventional steps from sesamol. The Claisen rearrangement of allyl sesamyl ether occurred predominantly to the unhindered side; O-methylation and base-catalyzed isomerization yielded the requisite propenylbenzene.</p>

<p>The vicinal analogs <strong>V</strong> and <strong>VI</strong> were both prepared from the corresponding benzaldehydes by condensation with nitroethane followed by reduction of the resulting nitrostyrene as described above. The properties of these products, together with those of the 3,4,5-analogs for comparison, are listed in the <strong>Table</strong>.</p>

<div class="tbl left">
<p><strong>Physical and pharmacological properties</strong><br><br></p>
<TABLE border="1" cellpadding="3"><tr><td><strong>Compound</strong></td><td><strong>Nitrostyrene mp</strong></td><td><strong>Base�HCl mp</strong></td>
<td><strong>ED<a href="shulgin.meo-34-dialkoxyamphetamines.html#notes"><sup>a</sup></a> (mice)</strong></td>
<td><strong>LD<sub>50</sub> (mice)</strong></td>
<td><strong>ED<a href="shulgin.meo-34-dialkoxyamphetamines.html#notes"><sup>b</sup></a> (human)</strong></td>
<td><strong>M.U.<a href="shulgin.meo-34-dialkoxyamphetamines.html#notes"><sup>c</sup></a></strong></td>
</tr><tr>
  <td> <strong>II</strong>) TMA<a href="shulgin.meo-34-dialkoxyamphetamines.html#notes"><sup>d</sup></a></td>
  <td><div align="right">94&deg;C</div></td>
  <td><div align="right">209&deg;C</div></td>
  <td><div align="right">20 mg/kg</div></td>
  <td><div align="right">260 mg/kg</div></td>
  <td><div align="right">1700 &micro;g/kg</div></td>
  <td><div align="right">2.2</div></td></tr><tr>
  <td><strong>II</strong>) MMDA</td>
  <td><div align="right">110&deg;C</div></td>
  <td><div align="right">191&deg;C</div></td>
  <td><div align="right">35 mg/kg</div></td>
  <td><div align="right">150 mg/kg</div></td>
  <td><div align="right">1400 &micro;g/kg</div></td>
  <td><div align="right">2.7</div></td></tr><tr>
  <td><strong>III</strong>) TMA-2<a href="shulgin.meo-34-dialkoxyamphetamines.html#notes"><sup>e</sup></a></td>
  <td><div align="right">102&deg;C</div></td>
  <td><div align="right">181&deg;C</div></td>
  <td><div align="right">15 mg/kg</div></td>
  <td><div align="right">120 mg/kg</div></td>
  <td><div align="right">220 &micro;g/kg</div></td>
  <td><div align="right">17.0</div></td></tr><tr><td><strong>IV</strong>) MMDA-2</td><td><div align="right">163&deg;C</div></td>
  <td><div align="right">187&deg;C</div></td>
  <td><div align="right">20 mg/kg</div></td>
  <td><div align="right">130 mg/kg</div></td>
  <td><div align="right">180 &micro;g/kg</div></td>
  <td><div align="right">21.0</div></td></tr><tr><td><strong>V</strong>) TMA-3</td><td><div align="right">57&deg;C</div></td>
  <td><div align="right">149&deg;C</div></td>
  <td><div align="right">35 mg/kg</div></td>
  <td><div align="right">120 mg/kg</div></td>
  <td><div align="right">>1900 &micro;g/kg</div></td>
  <td><div align="right"><2.0</></td></tr><tr>
    <td><strong>VI</strong>) MMDA-3a</td>
    <td><div align="right">106&deg;C</div></td>
    <td><div align="right">154&deg;C</div></td>
    <td><div align="right">25 mg/kg</div></td>
    <td><div align="right">40 mg/kg</div></td>
    <td><div align="right">210 &micro;g/kg</div></td>
    <td><div align="right">18.0</div></td></tr></TABLE>

<ol style="list-style-type:lower-alpha;">
	<li><span class="oli">Effective dosage (as free base in saline, i.p.) at which behavioral changes were  observed.</span></li>
	<li><span class="oli">Effective dosage (as free base, <em>per os</em>) defined as the arithmetical mean between the<br>minimum detectable dosage and the dosage above which there is a prolongation rather<br>than an intensification of the psychotomimetic syndrome.</span></li>
	<li><span class="oli">Mescaline Units (human). The quotient of the effective dosage of mescaline (assumed to<br>be 3750 &micro;g/kg as the base) divided by the effective dosage of the substance in question.<br>It permits a direct comparison of relative potencies, based on mescaline = 1.</span></li>
	<li><span class="oli">Physical data from <a href="shulgin.meo-34-dialkoxyamphetamines.html#refs">4</a>.</span></li>
	<li><span class="oli">Literature values for the nitrostyrene mp 101�C and for the base�HCl, 187�C, see<br>
	  V. Bruckner, <strong><a href="http://www.erowid.org/archive/rhodium/pdf/pseudonitrosite.bruckner.1933-jpc268.pdf">J. Prakt. Chem. 138, 268 (1933)</a></strong></span></li>
</ol>
</div>

<p>Behavioral and toxicological studies were performed on male Swiss white mice, and these results are also recorded in the <strong>Table</strong>. All four isomers were found to be somewhat more toxic than the 3,4,5-substituted analogs. Compound <strong>VI</strong>, MMDA-3a, was the most toxic of the group and it alone produced clonic convulsions and vocalization prior to death. The other compounds led to easy deaths, apparently due to respiratory paralysis. All compounds displayed initial behavioral changes at the levels listed. The responses observed were light tremors accompanied by rapid scratching and a huddling tendency. These effects disappeared within 3 h, and there were no noticeable after-effects.</p>

<p>The intoxication syndrome in human subjects, resulting from the quantities shown in the <strong>Table</strong>, is qualitatively similar to that which results from mescaline, except that the color effects, and to a large extent the nausea, are absent. As a generalization, the MMDA series leads to the more empathic and pleasant responses, whereas personal anxiety and restlessness were common with TMA-2. The vicinal analog, TMA-3, demonstrated neither physical nor psychotropic effects, even in dosages in excess of those shown to be adequate for TMA and MMDA. With the other three ortho-methoxy derivatives, however, hypnogogic hallucinatory synthesis and total recall are present and are similar to mescaline.</p>

<img src="pictures/space/8x8.gif" width="710" height="8" border="0">
</div>

<div class="refs">
	<a name="refs"></a>
	<h2>References</h2>
	<ol>
	<li><span class="oli">Psychotomimetic Amphetamines, part <strong>II</strong>; for part <strong>I</strong> see <a href="shulgin.meo-34-dialkoxyamphetamines.html#refs">3</a>.</span></li>
	<li><span class="oli">D. I. Peretz, J. R. Smythies, and W. C. Gibson, <strong>J. Mental Sci. 101, 317 (1955)</strong><br>A. T. Shulgin, S. Bunnell, and T. Sargent III. <strong><a href="tma.shulgin.html">Nature 189, 1011 (1961)</a></strong></span></li>
	<li><span class="oli">A. T. Shulgin, <strong><a href="mmda.shulgin.html">Nature, 201, 1120 (1964)</a></strong>. (To be considered paper <strong>I</strong> of this series.)</span></li>
	<li><span class="oli">A. T. Shulgin, <strong><a href="mescaline.analogs.shulgin.html">Experientia 19, 127 (1963)</a></strong></span></li>
	<li><span class="oli">F. A. Ramirez and A. Burger, <strong><a href="lah.phenolic.nitrostyrenes.html">J. Am. chem. Soc. 72, 2781 (1950)</a></strong></span></li>
	</ol>

</div>

</body>
</html>
